Management of presumed benign ovarian tumors: updated French guidelines
Abstract Transvaginal pelvic ultrasound is the first-line imaging examination for presumed benign ovarian tumors (PBOT) in adult women (Grade A). Ultrasound is sufficient for characterizing a unilocular anechoic cyst smaller than 7 cm (Grade A). Magnetic resonance imaging is the recommended second-l...
Gespeichert in:
| Veröffentlicht in: | European journal of obstetrics & gynecology and reproductive biology 2014-12, Vol.183, p.52-58 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 58 |
|---|---|
| container_issue | |
| container_start_page | 52 |
| container_title | European journal of obstetrics & gynecology and reproductive biology |
| container_volume | 183 |
| creator | Brun, J.-L Fritel, X Aubard, Y Borghese, B Bourdel, N Chabbert-Buffet, N Collinet, P Deffieux, X Dubernard, G Huchon, C Kalfa, N Lahlou, N Marret, H Pienkowski, C Sevestre, H Thomassin-Naggara, I Levêque, J |
| description | Abstract Transvaginal pelvic ultrasound is the first-line imaging examination for presumed benign ovarian tumors (PBOT) in adult women (Grade A). Ultrasound is sufficient for characterizing a unilocular anechoic cyst smaller than 7 cm (Grade A). Magnetic resonance imaging is the recommended second-line investigation for indeterminate masses or masses larger than 7 cm (Grade B). Serum CA-125 assay is not recommended for first-line diagnosis in adult women (Grade C). In women with a unilocular anechoic cyst, hormone therapy is ineffective and not recommended (Grade A). Ultrasound-guided aspiration is not recommended (Grade B). Abstention is an option in adult women with a unilocular asymptomatic anechoic cyst smaller than 10 cm and no history of cancer (Grade B). If symptoms develop, laparoscopy is the gold standard for surgical treatment of PBOT (Grade A). Conservative surgical treatment (cystectomy) should be preferred to oophorectomy in pre-menopausal women without a previous history of cancer (Grade C). In cases of suspected adnexal torsion, laparoscopic surgical exploration is recommended (Grade B). Conservative treatment or detorsion without oophorectomy is recommended for pre-menopausal women regardless of the estimated torsion duration and macroscopic appearance of the ovary (Grade B). During pregnancy, expectant management is recommended for unilocular asymptomatic anechoic cysts smaller than 6 cm (Grade C). |
| doi_str_mv | 10.1016/j.ejogrb.2014.10.012 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1652431214</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0301211514005363</els_id><sourcerecordid>1652431214</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-87d224f7327f56957b728ddf4a4f5cc6c18ddfddb9cb28cc3e094a3429af03c43</originalsourceid><addsrcrecordid>eNqFkU1P3DAQhi1EVRboP0BVjlyy9fgj2fSAhBAflah6AM6WY0-2ThN7aydI_HscLeXApXMZzcw7M5pnCDkDugYK1bd-jX3YxnbNKIicWlNgB2QFm5qVdSXFIVlRTqFkAPKIHKfU02ycN5_JEZOiAi75itz-1F5vcUQ_FaErdhHTPKItWvRu64vwrKPTvpjmMcT0vZh3Vk-5fBPRm9_FdnYWB-cxnZJPnR4SfnnzJ-Tp5vrx6q68_3X74-ryvjQC6qnc1JYx0dWc1Z2sGlm3NdtY2wktOmlMZWCJrG0b07KNMRxpIzQXrNEd5UbwE3K-n7uL4e-MaVKjSwaHQXsMc1JQSSY4MFikYi81MaQUsVO76EYdXxRQtSBUvdojVAvCJZsR5ravbxvmNpN4b_rHLAsu9gLMdz47jCoZl3GgdRHNpGxw_9vwcYDJDJ3Rwx98wdSHOfrMUIFKTFH1sLxx-SIISiWvOH8FvSSY-w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1652431214</pqid></control><display><type>article</type><title>Management of presumed benign ovarian tumors: updated French guidelines</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Brun, J.-L ; Fritel, X ; Aubard, Y ; Borghese, B ; Bourdel, N ; Chabbert-Buffet, N ; Collinet, P ; Deffieux, X ; Dubernard, G ; Huchon, C ; Kalfa, N ; Lahlou, N ; Marret, H ; Pienkowski, C ; Sevestre, H ; Thomassin-Naggara, I ; Levêque, J</creator><creatorcontrib>Brun, J.-L ; Fritel, X ; Aubard, Y ; Borghese, B ; Bourdel, N ; Chabbert-Buffet, N ; Collinet, P ; Deffieux, X ; Dubernard, G ; Huchon, C ; Kalfa, N ; Lahlou, N ; Marret, H ; Pienkowski, C ; Sevestre, H ; Thomassin-Naggara, I ; Levêque, J ; on behalf of the Collège National des Gynécologues Obstétriciens Français ; Collège National des Gynécologues Obstétriciens Français</creatorcontrib><description>Abstract Transvaginal pelvic ultrasound is the first-line imaging examination for presumed benign ovarian tumors (PBOT) in adult women (Grade A). Ultrasound is sufficient for characterizing a unilocular anechoic cyst smaller than 7 cm (Grade A). Magnetic resonance imaging is the recommended second-line investigation for indeterminate masses or masses larger than 7 cm (Grade B). Serum CA-125 assay is not recommended for first-line diagnosis in adult women (Grade C). In women with a unilocular anechoic cyst, hormone therapy is ineffective and not recommended (Grade A). Ultrasound-guided aspiration is not recommended (Grade B). Abstention is an option in adult women with a unilocular asymptomatic anechoic cyst smaller than 10 cm and no history of cancer (Grade B). If symptoms develop, laparoscopy is the gold standard for surgical treatment of PBOT (Grade A). Conservative surgical treatment (cystectomy) should be preferred to oophorectomy in pre-menopausal women without a previous history of cancer (Grade C). In cases of suspected adnexal torsion, laparoscopic surgical exploration is recommended (Grade B). Conservative treatment or detorsion without oophorectomy is recommended for pre-menopausal women regardless of the estimated torsion duration and macroscopic appearance of the ovary (Grade B). During pregnancy, expectant management is recommended for unilocular asymptomatic anechoic cysts smaller than 6 cm (Grade C).</description><identifier>ISSN: 0301-2115</identifier><identifier>EISSN: 1872-7654</identifier><identifier>DOI: 10.1016/j.ejogrb.2014.10.012</identifier><identifier>PMID: 25461353</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Biomarkers ; Contraceptives, Oral, Hormonal - therapeutic use ; Danazol - therapeutic use ; Disease Management ; Drug Therapy, Combination ; Female ; France ; Humans ; Imaging ; Laparoscopy ; Magnetic Resonance Imaging ; Neoplasms - diagnosis ; Neoplasms - therapy ; Obstetrics and Gynecology ; Ovarian cyst ; Ovarian Neoplasms - diagnosis ; Ovarian Neoplasms - therapy ; Ovariectomy ; Pregnancy ; Progestins - therapeutic use ; Treatment ; Ultrasonography</subject><ispartof>European journal of obstetrics & gynecology and reproductive biology, 2014-12, Vol.183, p.52-58</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2014 Elsevier Ireland Ltd</rights><rights>Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-87d224f7327f56957b728ddf4a4f5cc6c18ddfddb9cb28cc3e094a3429af03c43</citedby><cites>FETCH-LOGICAL-c417t-87d224f7327f56957b728ddf4a4f5cc6c18ddfddb9cb28cc3e094a3429af03c43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0301211514005363$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25461353$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brun, J.-L</creatorcontrib><creatorcontrib>Fritel, X</creatorcontrib><creatorcontrib>Aubard, Y</creatorcontrib><creatorcontrib>Borghese, B</creatorcontrib><creatorcontrib>Bourdel, N</creatorcontrib><creatorcontrib>Chabbert-Buffet, N</creatorcontrib><creatorcontrib>Collinet, P</creatorcontrib><creatorcontrib>Deffieux, X</creatorcontrib><creatorcontrib>Dubernard, G</creatorcontrib><creatorcontrib>Huchon, C</creatorcontrib><creatorcontrib>Kalfa, N</creatorcontrib><creatorcontrib>Lahlou, N</creatorcontrib><creatorcontrib>Marret, H</creatorcontrib><creatorcontrib>Pienkowski, C</creatorcontrib><creatorcontrib>Sevestre, H</creatorcontrib><creatorcontrib>Thomassin-Naggara, I</creatorcontrib><creatorcontrib>Levêque, J</creatorcontrib><creatorcontrib>on behalf of the Collège National des Gynécologues Obstétriciens Français</creatorcontrib><creatorcontrib>Collège National des Gynécologues Obstétriciens Français</creatorcontrib><title>Management of presumed benign ovarian tumors: updated French guidelines</title><title>European journal of obstetrics & gynecology and reproductive biology</title><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><description>Abstract Transvaginal pelvic ultrasound is the first-line imaging examination for presumed benign ovarian tumors (PBOT) in adult women (Grade A). Ultrasound is sufficient for characterizing a unilocular anechoic cyst smaller than 7 cm (Grade A). Magnetic resonance imaging is the recommended second-line investigation for indeterminate masses or masses larger than 7 cm (Grade B). Serum CA-125 assay is not recommended for first-line diagnosis in adult women (Grade C). In women with a unilocular anechoic cyst, hormone therapy is ineffective and not recommended (Grade A). Ultrasound-guided aspiration is not recommended (Grade B). Abstention is an option in adult women with a unilocular asymptomatic anechoic cyst smaller than 10 cm and no history of cancer (Grade B). If symptoms develop, laparoscopy is the gold standard for surgical treatment of PBOT (Grade A). Conservative surgical treatment (cystectomy) should be preferred to oophorectomy in pre-menopausal women without a previous history of cancer (Grade C). In cases of suspected adnexal torsion, laparoscopic surgical exploration is recommended (Grade B). Conservative treatment or detorsion without oophorectomy is recommended for pre-menopausal women regardless of the estimated torsion duration and macroscopic appearance of the ovary (Grade B). During pregnancy, expectant management is recommended for unilocular asymptomatic anechoic cysts smaller than 6 cm (Grade C).</description><subject>Biomarkers</subject><subject>Contraceptives, Oral, Hormonal - therapeutic use</subject><subject>Danazol - therapeutic use</subject><subject>Disease Management</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>France</subject><subject>Humans</subject><subject>Imaging</subject><subject>Laparoscopy</subject><subject>Magnetic Resonance Imaging</subject><subject>Neoplasms - diagnosis</subject><subject>Neoplasms - therapy</subject><subject>Obstetrics and Gynecology</subject><subject>Ovarian cyst</subject><subject>Ovarian Neoplasms - diagnosis</subject><subject>Ovarian Neoplasms - therapy</subject><subject>Ovariectomy</subject><subject>Pregnancy</subject><subject>Progestins - therapeutic use</subject><subject>Treatment</subject><subject>Ultrasonography</subject><issn>0301-2115</issn><issn>1872-7654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1P3DAQhi1EVRboP0BVjlyy9fgj2fSAhBAflah6AM6WY0-2ThN7aydI_HscLeXApXMZzcw7M5pnCDkDugYK1bd-jX3YxnbNKIicWlNgB2QFm5qVdSXFIVlRTqFkAPKIHKfU02ycN5_JEZOiAi75itz-1F5vcUQ_FaErdhHTPKItWvRu64vwrKPTvpjmMcT0vZh3Vk-5fBPRm9_FdnYWB-cxnZJPnR4SfnnzJ-Tp5vrx6q68_3X74-ryvjQC6qnc1JYx0dWc1Z2sGlm3NdtY2wktOmlMZWCJrG0b07KNMRxpIzQXrNEd5UbwE3K-n7uL4e-MaVKjSwaHQXsMc1JQSSY4MFikYi81MaQUsVO76EYdXxRQtSBUvdojVAvCJZsR5ravbxvmNpN4b_rHLAsu9gLMdz47jCoZl3GgdRHNpGxw_9vwcYDJDJ3Rwx98wdSHOfrMUIFKTFH1sLxx-SIISiWvOH8FvSSY-w</recordid><startdate>20141201</startdate><enddate>20141201</enddate><creator>Brun, J.-L</creator><creator>Fritel, X</creator><creator>Aubard, Y</creator><creator>Borghese, B</creator><creator>Bourdel, N</creator><creator>Chabbert-Buffet, N</creator><creator>Collinet, P</creator><creator>Deffieux, X</creator><creator>Dubernard, G</creator><creator>Huchon, C</creator><creator>Kalfa, N</creator><creator>Lahlou, N</creator><creator>Marret, H</creator><creator>Pienkowski, C</creator><creator>Sevestre, H</creator><creator>Thomassin-Naggara, I</creator><creator>Levêque, J</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20141201</creationdate><title>Management of presumed benign ovarian tumors: updated French guidelines</title><author>Brun, J.-L ; Fritel, X ; Aubard, Y ; Borghese, B ; Bourdel, N ; Chabbert-Buffet, N ; Collinet, P ; Deffieux, X ; Dubernard, G ; Huchon, C ; Kalfa, N ; Lahlou, N ; Marret, H ; Pienkowski, C ; Sevestre, H ; Thomassin-Naggara, I ; Levêque, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-87d224f7327f56957b728ddf4a4f5cc6c18ddfddb9cb28cc3e094a3429af03c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Biomarkers</topic><topic>Contraceptives, Oral, Hormonal - therapeutic use</topic><topic>Danazol - therapeutic use</topic><topic>Disease Management</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>France</topic><topic>Humans</topic><topic>Imaging</topic><topic>Laparoscopy</topic><topic>Magnetic Resonance Imaging</topic><topic>Neoplasms - diagnosis</topic><topic>Neoplasms - therapy</topic><topic>Obstetrics and Gynecology</topic><topic>Ovarian cyst</topic><topic>Ovarian Neoplasms - diagnosis</topic><topic>Ovarian Neoplasms - therapy</topic><topic>Ovariectomy</topic><topic>Pregnancy</topic><topic>Progestins - therapeutic use</topic><topic>Treatment</topic><topic>Ultrasonography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brun, J.-L</creatorcontrib><creatorcontrib>Fritel, X</creatorcontrib><creatorcontrib>Aubard, Y</creatorcontrib><creatorcontrib>Borghese, B</creatorcontrib><creatorcontrib>Bourdel, N</creatorcontrib><creatorcontrib>Chabbert-Buffet, N</creatorcontrib><creatorcontrib>Collinet, P</creatorcontrib><creatorcontrib>Deffieux, X</creatorcontrib><creatorcontrib>Dubernard, G</creatorcontrib><creatorcontrib>Huchon, C</creatorcontrib><creatorcontrib>Kalfa, N</creatorcontrib><creatorcontrib>Lahlou, N</creatorcontrib><creatorcontrib>Marret, H</creatorcontrib><creatorcontrib>Pienkowski, C</creatorcontrib><creatorcontrib>Sevestre, H</creatorcontrib><creatorcontrib>Thomassin-Naggara, I</creatorcontrib><creatorcontrib>Levêque, J</creatorcontrib><creatorcontrib>on behalf of the Collège National des Gynécologues Obstétriciens Français</creatorcontrib><creatorcontrib>Collège National des Gynécologues Obstétriciens Français</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of obstetrics & gynecology and reproductive biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brun, J.-L</au><au>Fritel, X</au><au>Aubard, Y</au><au>Borghese, B</au><au>Bourdel, N</au><au>Chabbert-Buffet, N</au><au>Collinet, P</au><au>Deffieux, X</au><au>Dubernard, G</au><au>Huchon, C</au><au>Kalfa, N</au><au>Lahlou, N</au><au>Marret, H</au><au>Pienkowski, C</au><au>Sevestre, H</au><au>Thomassin-Naggara, I</au><au>Levêque, J</au><aucorp>on behalf of the Collège National des Gynécologues Obstétriciens Français</aucorp><aucorp>Collège National des Gynécologues Obstétriciens Français</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of presumed benign ovarian tumors: updated French guidelines</atitle><jtitle>European journal of obstetrics & gynecology and reproductive biology</jtitle><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><date>2014-12-01</date><risdate>2014</risdate><volume>183</volume><spage>52</spage><epage>58</epage><pages>52-58</pages><issn>0301-2115</issn><eissn>1872-7654</eissn><abstract>Abstract Transvaginal pelvic ultrasound is the first-line imaging examination for presumed benign ovarian tumors (PBOT) in adult women (Grade A). Ultrasound is sufficient for characterizing a unilocular anechoic cyst smaller than 7 cm (Grade A). Magnetic resonance imaging is the recommended second-line investigation for indeterminate masses or masses larger than 7 cm (Grade B). Serum CA-125 assay is not recommended for first-line diagnosis in adult women (Grade C). In women with a unilocular anechoic cyst, hormone therapy is ineffective and not recommended (Grade A). Ultrasound-guided aspiration is not recommended (Grade B). Abstention is an option in adult women with a unilocular asymptomatic anechoic cyst smaller than 10 cm and no history of cancer (Grade B). If symptoms develop, laparoscopy is the gold standard for surgical treatment of PBOT (Grade A). Conservative surgical treatment (cystectomy) should be preferred to oophorectomy in pre-menopausal women without a previous history of cancer (Grade C). In cases of suspected adnexal torsion, laparoscopic surgical exploration is recommended (Grade B). Conservative treatment or detorsion without oophorectomy is recommended for pre-menopausal women regardless of the estimated torsion duration and macroscopic appearance of the ovary (Grade B). During pregnancy, expectant management is recommended for unilocular asymptomatic anechoic cysts smaller than 6 cm (Grade C).</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>25461353</pmid><doi>10.1016/j.ejogrb.2014.10.012</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0301-2115 |
| ispartof | European journal of obstetrics & gynecology and reproductive biology, 2014-12, Vol.183, p.52-58 |
| issn | 0301-2115 1872-7654 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1652431214 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Biomarkers Contraceptives, Oral, Hormonal - therapeutic use Danazol - therapeutic use Disease Management Drug Therapy, Combination Female France Humans Imaging Laparoscopy Magnetic Resonance Imaging Neoplasms - diagnosis Neoplasms - therapy Obstetrics and Gynecology Ovarian cyst Ovarian Neoplasms - diagnosis Ovarian Neoplasms - therapy Ovariectomy Pregnancy Progestins - therapeutic use Treatment Ultrasonography |
| title | Management of presumed benign ovarian tumors: updated French guidelines |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T21%3A46%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20presumed%20benign%20ovarian%20tumors:%20updated%20French%20guidelines&rft.jtitle=European%20journal%20of%20obstetrics%20&%20gynecology%20and%20reproductive%20biology&rft.au=Brun,%20J.-L&rft.aucorp=on%20behalf%20of%20the%20Coll%C3%A8ge%20National%20des%20Gyn%C3%A9cologues%20Obst%C3%A9triciens%20Fran%C3%A7ais&rft.date=2014-12-01&rft.volume=183&rft.spage=52&rft.epage=58&rft.pages=52-58&rft.issn=0301-2115&rft.eissn=1872-7654&rft_id=info:doi/10.1016/j.ejogrb.2014.10.012&rft_dat=%3Cproquest_cross%3E1652431214%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1652431214&rft_id=info:pmid/25461353&rft_els_id=S0301211514005363&rfr_iscdi=true |